Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study

www.annalsofoncology.org/article/S092...

Incredible improvement for patient with microsatellite unstable metastatic colorectal cancer. MSI is a Ferrari ride for cancer evolution, but immunotherapy is the perfect match to stop that ride !!! Don’t think that we will see similar success for other „biomarkers“ soon.
nej.md/4eGp1tj

Nice overview on "Emerging ADCs for platinum-refractory UC" from #BLADDR in Vienna! 🚨

ADCs and small molecules came to stay and will likely advance cancer treatment of multiple cancers significantly !

Differential diagnosis of abdominal pain